[Some aspects of interferon formation in white mice]

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• Influenza virus infection leads to significant viral load and interferon production in the lungs.
• Interferon induction in the nasal cavity is low despite sufficient viral accumulation.
• Systemic interferon levels correlate with low viremia.

Purpose of the Study:

• To investigate the efficacy of different administration routes of the interferon inducer ridostin (dsRNA) in mice.
• To determine the distribution and induction of interferon in respiratory tissues and blood following ridostin administration.
• To inform the development of effective interferon-based therapies for influenza.

Main Methods:

• Intranasal inoculation of mice with influenza virus (A/Aichi/2/68 strain).
• Administration of ridostin via intraperitoneal, intranasal, and aerogenic routes.
• Quantification of virus and interferon levels in lung, nasal cavity, blood, and brain tissues.
• Monitoring of interferon induction over time post-administration.

Main Results:

• Intranasal influenza infection resulted in high virus and interferon levels in the lungs.
• Intraperitoneal ridostin induced high blood interferon but not in the respiratory tract or brain.
• Intranasal and aerogenic ridostin effectively induced interferon in the upper respiratory tract and lungs.
• Interferon levels in blood correlated with low viremia.

Conclusions:

• The route of administration significantly impacts interferon induction by ridostin.
• Respiratory administration of interferon inducers is crucial for targeting influenza in the respiratory tract.
• Development of specific dosage forms for respiratory application of interferon inducers is recommended for influenza treatment.